Key findings

Key limitations with the data presented were the relatively small sample size (n=59) and design of the pilot study.

In order to alleviate concerns surrounding true treatment effects, further research in the form of a randomised controlled trial is desirable.

The incremental cost-effectiveness ratio (ICER) for the ACT Now! intervention is £129 per QALY gained. This exploratory result represents a highly cost-effective intervention

What were we asked to look at?

We were asked to provide a high level overview of ACT Now! ACT Now! is a brief, guided self-help programme aimed at improving both glycaemic control and emotional well-being of people with Type 2 diabetes. 

Why is this important?

ACT Now! is based upon psychological theory and intends to encourage people to live the kinds of lives they want, and uses this, not health itself, as motivation to change health-related behaviours. ACT Now! is designed for people who have not managed to make changes to key self-management behaviours using standard care and education and/or where anxiety or depression complicates the clinical picture. 

Referred by

Submission by NHS Grampian